Skip to main content
. 2020 Feb 25;63(2):195–204. doi: 10.5468/ogs.2020.63.2.195

Fig. 2. An analysis of changes from baseline measurements of 4 emotional symptoms surveys versus treatment with an oxaloacetate/vitamin C mix or placebo in 48 participants with premenstrual syndrome.

Fig. 2